Ginkgo biloba (EGb 761) as a phytotherapeutic agent used in otoneurology, psychiatry, and ophthalmology. We studied the efficacy of therapy with EGb 761 in 72 patients (44 male and 28 female) with chronic cochleovestibular disorders. We used pure-tone audiology, measuring pure-tone average, speech reception threshold, and speech discrimination score. Then we used craniocorpography to measure lateral body sway and angular deviation. Finally, we used nystagmography (central nystagmic frequency). Also, we assessed subjectively the variation in patients' comfort. We concluded that EGb 761 has a very good effect on both postural and oculovestibular reflexes. Also, hearing was improved, and patients' comfort was considered to be heightened by the therapy.

Ear Nose and Throat Department 3rd Medical Faculty Charles University Srobárova 50 Prague 100 34 Czech Republic